- Johnson & Johnson to pay $5.5bn settlement over baby powder lawsuits The Independent —
- Johnson & Johnson settles US talcum powder lawsuit with $5.5bn payout Financial Times —
- Johnson & Johnson Agrees to Pay $5.5 Billion to Settle Talc Lawsuits Wall Street Journal —
- J&Jās first-quarter profit beats estimates even as Stelara sales disappoint CTV News —
- Johnson & Johnson offers $5.5 bn to settle talc lawsuits IOL —
- Johnson & Johnson to pay $5.5 billion to settle talc-related cancer claims Business Standard —
- Johnson & Johnson reaches proposed $5.5B settlement to resolve talc lawsuits tied to ovarian cancer claims Anadolu Agency —
- J&Jās first-quarter profit beats estimates even as Stelara sales disappoint The Globe and Mail —
- Johnson & Johnson reaches proposed $5.5B talcum powder settlement UPI —
- J&J announces $5.5 billion settlement of talc lawsuits RTE —
- J&J offers $5.5bn settlement in lawsuits claiming talc link to cancer Al Jazeera —
- J&Jās First-Quarter Sales Grow on Cancer-Drug Strength Wall Street Journal —
- Johnson & Johnson offers $5.5 billion to settle talc lawsuits CBS News —
- Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits MyJoyOnline —
- Johnson & Johnson offers up to $5.5bn to settle baby powder lawsuits BBC News —
- Johnson & Johnson Non-GAAP EPS of $2.70 beats by $0.02, revenue of $24.06B beats by $450M Seeking Alpha —
- Johnson & Johnson announces $7 billion settlement of talc lawsuits The Straits Times —
- J&J's first-quarter profit beats estimates even as Stelara sales disappoint - Reuters Reuters —
- Earnings Snapshot: Johnson & Johnson tops Q1 expectations; boosts full-year outlook and increases quarterly dividend Seeking Alpha —
- J&J raises 2026 outlook as oncology products power Q1 beat Seeking Alpha —
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
Johnson & Johnson (J&J) is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey. The company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Along with Microsoft, Johnson & Johnson is one of only two U.S.-based companies that has a prime credit rating of AAA from S&P Global.
Also known as...
J&J and Johnson and Johnson